肺腺癌体积倍增时间:与主要组织学亚型及预后的相关性
本回顾性研究纳入2010年7月至2018年12月术前接受至少两次连续CT检查的268例肺腺癌患者,计算三维肿瘤分割的体积倍增时间(VDT)。VDT在不同主要组织学亚型间差异显著(P < .001),实性或微乳头亚型最短(229天),实性病灶VDT短于亚实性病灶(P < .001)。VDT(<400天)是DFS的独立危险因素(HR 2.6,P = .01),联合TNM分期可提升模型性能(C-index 0.69 vs 0.77,P = .002)。
要点
- 实性或微乳头为主型肺腺癌的VDT最短(229天),侵袭性可能更强。
- 实性病灶VDT(248天)短于部分实性(665天)和非实性(648天)病灶。
- VDT<400天是DFS的独立危险因素(HR 2.6),联合TNM分期可改善预后模型。
核心结论
- 肺腺癌的VDT因主要组织学亚型不同而差异显著,并对无病生存期具有额外预后价值。
研究设计与样本
- 回顾性研究,纳入2010年7月至2018年12月术前接受至少两次连续CT检查的患者268例(平均年龄64岁±8,143例男性)。
- 对两次CT图像进行三维肿瘤分割并计算VDT,采用Kruskal-Wallis检验比较不同主要组织学亚型及病灶类型的VDT。
- 生存分析纳入2017年7月前接受手术的患者148例(平均年龄64岁±8,89例男性),采用单变量和多变量Cox比例风险回归分析确定DFS的预测因素。
关键影像表现/征象
- 主要组织学亚型分布:贴壁型30例、腺泡型87例、乳头型109例、实性或微乳头型42例。
- 肺腺癌总体中位VDT为529天(四分位距278-872天)。
- 实性或微乳头亚型VDT最短(229天;四分位距77-530天)。
- 实性病灶VDT为248天,短于部分实性病灶(665天)和非实性病灶(648天)(P < .001)。
诊断标准与关键数值
- VDT<400天为DFS的独立危险因素(HR 2.6;P = .01),并与更高的TNM分期相关。
- 将VDT加入TNM分期后模型性能提升:TNM分期C-index为0.69,VDT联合TNM分期为0.77(P = .002)。
- VDT在不同主要组织学亚型间差异有统计学意义(P < .001)。
临床应用与阅片要点
- 阅片时测量并报告肺腺癌病灶的VDT,可为组织学亚型推断及预后评估提供参考。
- 实性病灶及实性或微乳头为主型腺癌的VDT较短,随访中可能需更密切关注。
- 将VDT与TNM分期联合用于DFS风险分层,可能改善预后模型性能。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Background The volume doubling time (VDT) is a key parameter in the differentiation of aggressive tumors from slow-growing tumors. How different histologic subtypes of primary lung adenocarcinomas vary in their VDT and the prognostic value of this measurement is unknown. Purpose To investigate differences in VDT between the predominant histologic subtypes of primary lung adenocarcinomas and to assess the correlation between VDT and prognosis. Materials and Methods This retrospective study included patients who underwent at least two serial CT examinations before undergoing operation between July 2010 and December 2018. Three-dimensional tumor segmentation was performed on two CT images and VDTs were calculated. VDTs were compared between predominant histologic subtypes and lesion types by using Kruskal-Wallis tests. Disease-free survival (DFS) was obtained in patients undergoing surgical procedures before July 2017. Univariable and multivariable Cox proportional hazards regression analyses were performed to determine predictors of DFS. Results Among 268 patients (mean age, 64 years ± 8 [standard deviation]; 143 men), there were 30 lepidic, 87 acinar, 109 papillary, and 42 solid or micropapillary predominant subtypes. The median VDT was 529 days (interquartile range, 278-872 days) for lung adenocarcinomas. VDTs differed across subtypes (P < .001) and were shortest in solid or micropapillary subtypes (229 days; interquartile range, 77-530 days). Solid lesions (VDT, 248 days) had shorter VDTs than subsolid lesions (part-solid lesions, 665 days; nonsolid lesions, 648 days) (P < .001). In the 148 patients (mean age, 64 years ± 8; 89 men) included in the survival analysis, 35 patients had disease recurrence and 17 patients died. VDT (<400 days) was an independent risk factor for poor DFS (hazard ratio, 2.6; P = .01) and higher TNM stage. Adding VDT to TNM stage improved model performance (C-index, 0.69 for TNM stage vs 0.77 for combined VDT class and TNM stage; P = .002). Conclusion Volume doubling times varied significantly according to the predominant histologic subtypes of lung adenocarcinoma and had additional prognostic value for disease-free survival. © RSNA, 2020 Online supplemental material is available for this article. See also the editorial by Ko in this issue.
引用
- Park S, Lee SM, Kim S, et al. Volume Doubling Times of Lung Adenocarcinomas: Correlation with Predominant Histologic Subtypes and Prognosis. Radiology. 2020. PMID: 32228296. doi:10.1148/radiol.2020191835
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。